New-Onset Diabetes Mellitus in COVID-19 : A Scoping Review
© 2023. The Author(s)..
INTRODUCTION: The coronavirus disease 2019 (COVID-19) pandemic became superimposed on the pre-existing obesity and diabetes mellitus (DM) pandemics. Since COVID-19 infection alters the metabolic equilibrium, it may induce pathophysiologic mechanisms that potentiate new-onset DM, and we evaluated this issue.
METHOD: A systematic review of the literature published from the 1 January 2020 until the 20 July 2023 was performed (PROSPERO registration number CRD42022341638). We included only full-text articles of both human clinical and randomized controlled trials published in English and enrolling adults (age > 18 years old) with ongoing or preceding COVID-19 in whom hyperglycemia was detected. The search was based on the following criteria: "(new-onset diabetes mellitus OR new-onset DM) AND (COVID-19) AND adults".
RESULTS: Articles on MEDLINE (n = 70) and the Web of Science database (n = 16) were included and analyzed by two researchers who selected 20 relevant articles. We found evidence of a bidirectional relationship between COVID-19 and DM.
CONCLUSIONS: This link operates as a pathophysiological mechanism supported by epidemiological data and also by the clinical and biological findings obtained from the affected individuals. The COVID-19 pandemic raised the incidence of DM through different pathophysiological and psychosocial factors.
| Errataetall: | |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:15 |
|---|---|
| Enthalten in: |
Diabetes therapy : research, treatment and education of diabetes and related disorders - 15(2024), 1 vom: 01. Jan., Seite 33-60 |
| Sprache: |
Englisch |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Revised 18.04.2024 published: Print-Electronic ErratumIn: Diabetes Ther. 2023 Nov 15;:. - PMID 37964156 Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1007/s13300-023-01465-7 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM362474907 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM362474907 | ||
| 003 | DE-627 | ||
| 005 | 20240418232306.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s13300-023-01465-7 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1379.xml |
| 035 | |a (DE-627)NLM362474907 | ||
| 035 | |a (NLM)37751143 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Pantea Stoian, Anca |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a New-Onset Diabetes Mellitus in COVID-19 |b A Scoping Review |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 18.04.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a ErratumIn: Diabetes Ther. 2023 Nov 15;:. - PMID 37964156 | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a © 2023. The Author(s). | ||
| 520 | |a INTRODUCTION: The coronavirus disease 2019 (COVID-19) pandemic became superimposed on the pre-existing obesity and diabetes mellitus (DM) pandemics. Since COVID-19 infection alters the metabolic equilibrium, it may induce pathophysiologic mechanisms that potentiate new-onset DM, and we evaluated this issue | ||
| 520 | |a METHOD: A systematic review of the literature published from the 1 January 2020 until the 20 July 2023 was performed (PROSPERO registration number CRD42022341638). We included only full-text articles of both human clinical and randomized controlled trials published in English and enrolling adults (age > 18 years old) with ongoing or preceding COVID-19 in whom hyperglycemia was detected. The search was based on the following criteria: "(new-onset diabetes mellitus OR new-onset DM) AND (COVID-19) AND adults" | ||
| 520 | |a RESULTS: Articles on MEDLINE (n = 70) and the Web of Science database (n = 16) were included and analyzed by two researchers who selected 20 relevant articles. We found evidence of a bidirectional relationship between COVID-19 and DM | ||
| 520 | |a CONCLUSIONS: This link operates as a pathophysiological mechanism supported by epidemiological data and also by the clinical and biological findings obtained from the affected individuals. The COVID-19 pandemic raised the incidence of DM through different pathophysiological and psychosocial factors | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Coronavirus disease 2019 | |
| 650 | 4 | |a Diabetes mellitus | |
| 650 | 4 | |a Hyperglycemia | |
| 650 | 4 | |a New-onset diabetes | |
| 650 | 4 | |a New-onset hyperglycemia | |
| 650 | 4 | |a Newly diagnosed diabetes | |
| 650 | 4 | |a Prediabetes | |
| 650 | 4 | |a Severe acute respiratory syndrome coronavirus-2 infection | |
| 700 | 1 | |a Bica, Ioana-Cristina |e verfasserin |4 aut | |
| 700 | 1 | |a Salmen, Teodor |e verfasserin |4 aut | |
| 700 | 1 | |a Al Mahmeed, Wael |e verfasserin |4 aut | |
| 700 | 1 | |a Al-Rasadi, Khalid |e verfasserin |4 aut | |
| 700 | 1 | |a Al-Alawi, Kamila |e verfasserin |4 aut | |
| 700 | 1 | |a Banach, Maciej |e verfasserin |4 aut | |
| 700 | 1 | |a Banerjee, Yajnavalka |e verfasserin |4 aut | |
| 700 | 1 | |a Ceriello, Antonio |e verfasserin |4 aut | |
| 700 | 1 | |a Cesur, Mustafa |e verfasserin |4 aut | |
| 700 | 1 | |a Cosentino, Francesco |e verfasserin |4 aut | |
| 700 | 1 | |a Firenze, Alberto |e verfasserin |4 aut | |
| 700 | 1 | |a Galia, Massimo |e verfasserin |4 aut | |
| 700 | 1 | |a Goh, Su-Yen |e verfasserin |4 aut | |
| 700 | 1 | |a Janez, Andrej |e verfasserin |4 aut | |
| 700 | 1 | |a Kalra, Sanjay |e verfasserin |4 aut | |
| 700 | 1 | |a Kapoor, Nitin |e verfasserin |4 aut | |
| 700 | 1 | |a Kempler, Peter |e verfasserin |4 aut | |
| 700 | 1 | |a Lessan, Nader |e verfasserin |4 aut | |
| 700 | 1 | |a Lotufo, Paulo |e verfasserin |4 aut | |
| 700 | 1 | |a Mikhailidis, Dimitri P |e verfasserin |4 aut | |
| 700 | 1 | |a Nibali, Luigi |e verfasserin |4 aut | |
| 700 | 1 | |a Papanas, Nikolaos |e verfasserin |4 aut | |
| 700 | 1 | |a Powell-Wiley, Tiffany |e verfasserin |4 aut | |
| 700 | 1 | |a Rizvi, Ali A |e verfasserin |4 aut | |
| 700 | 1 | |a Sahebkar, Amirhossein |e verfasserin |4 aut | |
| 700 | 1 | |a Santos, Raul D |e verfasserin |4 aut | |
| 700 | 1 | |a Toth, Peter P |e verfasserin |4 aut | |
| 700 | 1 | |a Viswanathan, Vijay |e verfasserin |4 aut | |
| 700 | 1 | |a Rizzo, Manfredi |e verfasserin |4 aut | |
| 700 | 0 | |a Cardiometabolic Panel of International Experts on Syndemic COVID-19 (CAPISCO) |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Diabetes therapy : research, treatment and education of diabetes and related disorders |d 2010 |g 15(2024), 1 vom: 01. Jan., Seite 33-60 |w (DE-627)NLM215796888 |x 1869-6953 |7 nnns |
| 773 | 1 | 8 | |g volume:15 |g year:2024 |g number:1 |g day:01 |g month:01 |g pages:33-60 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s13300-023-01465-7 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 15 |j 2024 |e 1 |b 01 |c 01 |h 33-60 | ||